Previous studies have reported that the silencing of CDK7 expression via a number of methods suppresses the growth and proliferation of liver carcinoma, lymphoma, leukemia, intestinal carcinoma and breast cancer cells (8–12). The gene discussed is CDK7; the disease is hepatocellular carcinoma.